Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

429 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR, Bonavida B. Jazirehi AR, et al. Among authors: bonavida b. Oncogene. 2005 Mar 24;24(13):2121-43. doi: 10.1038/sj.onc.1208349. Oncogene. 2005. PMID: 15789036 Review.
Free-radicals dependent and independent pathways of cddp-mediated cytotoxicity and apoptosis in ovarian tumor-cell lines.
Uslu R, Bonavida B. Uslu R, et al. Among authors: bonavida b. Int J Oncol. 1995 May;6(5):1003-9. doi: 10.3892/ijo.6.5.1003. Int J Oncol. 1995. PMID: 21556631
Sensitization of AIDS related non-Hodgkin's B lymphoma cell lines to cytotoxic drugs toxins by interferon-gamma.
Demidem A, Salahuddin Z, Lam T, Levine A, Khan R, Hober D, Bonavida B. Demidem A, et al. Among authors: bonavida b. Int J Oncol. 1996 Mar;8(3):461-8. doi: 10.3892/ijo.8.3.461. Int J Oncol. 1996. PMID: 21544383
Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis.
Itakura M, Mori S, Park NH, Bonavida B. Itakura M, et al. Among authors: bonavida b. Int J Oncol. 2000 Mar;16(3):591-7. doi: 10.3892/ijo.16.3.591. Int J Oncol. 2000. PMID: 10675494
Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis.
Garbán HJ, Bonavida B. Garbán HJ, et al. Among authors: bonavida b. Gynecol Oncol. 1999 May;73(2):257-64. doi: 10.1006/gyno.1999.5374. Gynecol Oncol. 1999. PMID: 10329044
Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities.
Cal C, Garban H, Jazirehi A, Yeh C, Mizutani Y, Bonavida B. Cal C, et al. Among authors: bonavida b. Curr Med Chem Anticancer Agents. 2003 Mar;3(2):77-93. doi: 10.2174/1568011033353443. Curr Med Chem Anticancer Agents. 2003. PMID: 12678904 Review.
Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Mori S, Murakami-Mori K, Bonavida B. Mori S, et al. Among authors: bonavida b. Anticancer Res. 1999 Mar-Apr;19(2A):1011-5. Anticancer Res. 1999. PMID: 10368647
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) for treatment of prostate cancer: first results and review of the literature.
Van Ophoven A, Ng CP, Patel B, Bonavida B, Belldegrun A. Van Ophoven A, et al. Among authors: bonavida b. Prostate Cancer Prostatic Dis. 1999 Dec;2(5/6):227-233. doi: 10.1038/sj.pcan.4500373. Prostate Cancer Prostatic Dis. 1999. PMID: 12497168
Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis.
Zisman A, Ng CP, Pantuck AJ, Bonavida B, Belldegrun AS. Zisman A, et al. Among authors: bonavida b. J Immunother. 2001 Nov-Dec;24(6):459-71. doi: 10.1097/00002371-200111000-00003. J Immunother. 2001. PMID: 11759069
Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions.
Bonavida B. Bonavida B. Oncogene. 2007 May 28;26(25):3629-36. doi: 10.1038/sj.onc.1210365. Oncogene. 2007. PMID: 17530016 Review.
429 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page